Hyperkalemia
94
11
15
59
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
28 trials with published results (30%)
Research Maturity
59 completed trials (63% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
10.6%
10 terminated out of 94 trials
85.5%
-1.0% vs benchmark
38%
36 trials in Phase 3/4
47%
28 of 59 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 59 completed trials
Clinical Trials (94)
Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
Observational Study on the Prevalence and Risk Factors of Patients With Hyperkalaemia in Brazil
Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia
Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study
Hyperkalemia Quality Improvement Program (HK-QIP) Study
Lower vs. Standard Insulin-Dextrose Doses for Treating Mild to Moderate Hyperkalemia in the Emergency Department
Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited Potassium Content in Patients With Chronic Kidney Disease: A Pilot Study
Lokelma for RAAS Maximisation in CKD & Heart Failure.
Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects
Prediction of Hyperkalemia in Dialysis Patients Through Waveform Analysis Using Wearable ECG
Adding Urea to the Final Dialysis Fluid
Potassium Supplementation in CKD
Dietary Potassium Liberalization in Pre-Dialysis Patients
A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia
IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors
5 Versus 10 Units of Insulin in Hyperkalemia Management
Potassium Correction for RAAS Optimization in Chronic Kidney Disease
Nurse-Led Nutritional Education for Moroccan Dialysis Patients
A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia
AK+ Guard™ Pilot Study in Chronic Kidney Disease: Outpatient Diagnostic Accuracy and Remote Monitoring